Pfizer Expects Drop in Revenue as Vaccine Demand Wanes
The drugmaker said revenue from Covid-19 products is slated to reach a low point this year due to a significant government stockpile on hand.
The drugmaker said revenue from Covid-19 products is slated to reach a low point this year due to a significant government stockpile on hand.